The Evolution of Clinical Trial Logistics in Turbulent TImes: Expert Tips from Suhail Ali

There’s a global supply crisis for the pharmaceutical industry. Far west, hospitals in the United States are challenged with a lack of liquid ibuprofen and far east, the disruptions between China and Australia are causing a supply drop. Combined with the constant innovative drug launches, pressure for timely drug deliveries on pharma’s supply chain is at its peak high.

In our latest exclusive interview, we have with us Suhail Ali, Vice President & Head of Clinical Delivery APAC at ICON PLC, who is leading a dedicated team of Clinical Research Associates and Clinical Trial Managers across the Asia-Pacific region, overseeing a diverse and dynamic portfolio of clinical trials.He shares his insights on the challenges and strategies in drug delivery logistics with a focus on the extremely fragmented APAC region. With more than 20 years in Clinical Project Management and Operations, find out from Suhail how companies are meticulously staying updated with regulatory requirements, ensuring that there’s minimal to no disruptions in the delivery.

In this interview, he addresses how his team demonstrated resilience throughout the turbulent pandemic, resulting in successful and uninterrupted medicinal drug delivery to every single patient. Additionally he shares his vision for the future, exploring how advancements in logistics and distribution technology can help reduce costs and improve the efficiency of clinical trials.

With logistics as the backbone of clinical trials, what’s the next best practice to come? Watch the full discussion with Suhail Ali